Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
icosabutate
DRUG
2 trials
Sponsors
Pronova BioPharma
, NorthSea Therapeutics B.V.
Conditions
Healthy
Non Alcoholic Steatohepatitis (NASH)
Phase 1
Icosabutate - A Phase I, Single Oral Dose, Safety, Tolerability and Pharmacokinetic Study in Healthy Subjects
Completed
NCT02364635
Pronova BioPharma
Healthy
Start: 2015-02-28
End: 2015-08-31
Updated: 2015-09-29
Phase 2
A Phase 2b Study of Icosabutate in Fatty Liver Disease
Completed
NCT04052516
NorthSea Therapeutics B.V.
Non Alcoholic Steatohepatitis (NASH)
Start: 2019-07-17
End: 2022-12-19
Updated: 2025-02-28
Related Papers
A phase IIb randomised-controlled trial of the FFAR1/FFAR4 agonist icosabutate in MASH.
2025-02-10
6 citations